- Home
- MDIA vs ATNM Comparison
MDIA vs ATNM Comparison
Compare MDIA & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDIA
- ATNM
- Stock Information
- Founded
- MDIA 2019
- ATNM 2000
- Country
- MDIA United States
- ATNM United States
- Employees
- MDIA N/A
- ATNM N/A
- Industry
- MDIA Broadcasting
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- MDIA Consumer Discretionary
- ATNM Health Care
- Exchange
- MDIA Nasdaq
- ATNM Nasdaq
- Market Cap
- MDIA 51.8M
- ATNM 51.5M
- IPO Year
- MDIA N/A
- ATNM N/A
- Fundamental
- Price
- MDIA $1.24
- ATNM $1.52
- Analyst Decision
- MDIA
- ATNM Strong Buy
- Analyst Count
- MDIA 0
- ATNM 3
- Target Price
- MDIA N/A
- ATNM $4.67
- AVG Volume (30 Days)
- MDIA 704.2K
- ATNM 491.4K
- Earning Date
- MDIA 05-20-2025
- ATNM 08-04-2025
- Dividend Yield
- MDIA N/A
- ATNM N/A
- EPS Growth
- MDIA N/A
- ATNM N/A
- EPS
- MDIA N/A
- ATNM N/A
- Revenue
- MDIA $116,895,000.00
- ATNM N/A
- Revenue This Year
- MDIA N/A
- ATNM N/A
- Revenue Next Year
- MDIA N/A
- ATNM N/A
- P/E Ratio
- MDIA N/A
- ATNM N/A
- Revenue Growth
- MDIA 268.03
- ATNM N/A
- 52 Week Low
- MDIA $0.79
- ATNM $1.03
- 52 Week High
- MDIA $5.73
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- MDIA 53.84
- ATNM 51.90
- Support Level
- MDIA $1.11
- ATNM $1.41
- Resistance Level
- MDIA $1.38
- ATNM $1.49
- Average True Range (ATR)
- MDIA 0.12
- ATNM 0.11
- MACD
- MDIA 0.01
- ATNM 0.00
- Stochastic Oscillator
- MDIA 51.11
- ATNM 58.33
About MDIA Mediaco Holding Inc.
MediaCo Holding Inc is a radio broadcasting media company operating in radio and digital advertising, premium programming, and events. It has two radio stations, WQHT-FM and WBLS-FM, which serve the New York City metropolitan area. The company generates revenue from radio and outdoor advertising sales, events including sponsorships and ticket sales, licensing, and syndication. The company has two business segments: the Audio segment and the Video segment. The company generates the majority of its revenue from the Audio segment.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.